Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study

• Kentaro Narita,
• Daisuke Ikeda,
• Mizuki Seki,
• Ami Fukumoto,
• Rikako Tabata,
• Yuka Uesugi,
• Daisuke Miura,
• Masami Takeuchi,
• Masahiro Doi,
• Yuka Umezawa,
• Yoshihito Otsuka,
• Kosei Matsue

Affiliations

Kentaro Narita

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Daisuke Ikeda

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Mizuki Seki

2 Postgraduate Education Center, Kameda Medical Center, Kamogawa-shi, Japan

Ami Fukumoto

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Rikako Tabata

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Yuka Uesugi

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Daisuke Miura

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Masami Takeuchi

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan

Masahiro Doi

3 Central laboratory, Kameda Medical Center, Kamogawa-shi, Japan

Yuka Umezawa

3 Central laboratory, Kameda Medical Center, Kamogawa-shi, Japan

Yoshihito Otsuka

3 Central laboratory, Kameda Medical Center, Kamogawa-shi, Japan

Kosei Matsue

1 Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan